In addition, we found an increase in the activating KIR2S2 [64], accompanied by a reduction of the inhibitory NKG2A molecule [75,76,77] on CTL, in our cohort of CLL patients. Here, KLRC1 is linked to B-cell chronic lymphocytic leukemia.